Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Raul Felipe Palma-Álvarez¹, Csaba Barta², Pieter Jan Carpentier³, Susan Carruthers⁴, Cleo L Crunelle⁵, Zsolt Demetrovics⁶, Geert Dom⁷, Stephen V Faraone⁸, Johan Franck⁹, Brian Johnson¹⁰, Máté Kapitány-Fövény¹¹, Sharlene Kaye¹², Maija Konstenius⁹, Frieda Matthys¹³, Franz Moggi¹⁴, Merete Møller¹⁵, Arnt Schellekens¹⁶, Arvid Skutle¹⁷, Geurt van de Glind¹⁸, Katelijne van Emmerik-van Oortmerssen¹⁹, Sofie Verspreet²⁰, Robert A Schoevers²¹, Sara Wallhed²², Frances R Levin²³, Lara Grau-López¹, Miguel Casas¹, Wim van den Brink²⁴, Josep Antoni Ramos-Quiroga²⁵; IASP Research Group

Affiliations

¹ Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary.
³ Reinier van Arkel mental health institute, 's-Hertogenbosch, The Netherlands.
⁴ National Drug Research Institute, Curtin University, Perth, Australia.
⁵ Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium; Toxicological Center, Antwerp University, Antwerp, Belgium.
⁶ Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.
⁷ Antwerp University (UA), Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp, Belgium; Psychiatric Center Mutiversum, Boechout, Belgium.
⁸ Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical Center, Syracuse, NY, USA.
⁹ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Departments of Psychiatry and of Anesthesia, SUNY Upstate Medical Center, Syracuse, NY, USA.
¹¹ Nyírő Gyula National Institute of Psychiatry and Addictions, Budapest, Hungary; Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.
¹² National Drug and Alcohol Research Center, University of New South Wales, Sydney, Australia.
¹³ Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
¹⁴ University Hospital of Psychiatry and Psychotherapy, University of Bern, Switzerland.
¹⁵ Department for Substance Abuse Treatment, Østfold Hospital Trust, Norway.
¹⁶ Department of Psychiatry, Radboudumc, Donders Institute for Brain, Cognition and Behavior, Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), Nijmegen, The Netherlands.
¹⁷ Bergen Clinics Foundation, Bergen, Norway.
¹⁸ ICASA Foundation, University of Amsterdam, Amsterdam, The Netherlands.
¹⁹ Arkin Mental Health and Addiction Treatment Center, Amsterdam, The Netherlands; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
²⁰ Psychiatric Center Mutiversum, Boechout, Belgium.
²¹ University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
²² Stockholm Centre for Dependency Disorders, Sweden.
²³ Columbia University, the New York State Psychiatric Institute, New York, NY, USA.
²⁴ Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
²⁵ Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jaramos@vhebron.net.

PMID: 32561156
DOI: 10.1016/j.rpsm.2020.04.013

Free article

Multicenter Study

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Raul Felipe Palma-Álvarez et al. Span J Psychiatry Ment Health. 2023 Jan-Mar.

Free article

. 2023 Jan-Mar;16(1):11-15.

doi: 10.1016/j.rpsm.2020.04.013. Epub 2020 Jun 16.

Authors

Affiliations

¹ Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
² Institute of Medical Chemistry, Molecular Biology, Pathobiochemistry, Semmelweis University, Budapest, Hungary.
³ Reinier van Arkel mental health institute, 's-Hertogenbosch, The Netherlands.
⁴ National Drug Research Institute, Curtin University, Perth, Australia.
⁵ Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium; Toxicological Center, Antwerp University, Antwerp, Belgium.
⁶ Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary.
⁷ Antwerp University (UA), Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp, Belgium; Psychiatric Center Mutiversum, Boechout, Belgium.
⁸ Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical Center, Syracuse, NY, USA.
⁹ Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Departments of Psychiatry and of Anesthesia, SUNY Upstate Medical Center, Syracuse, NY, USA.
¹¹ Nyírő Gyula National Institute of Psychiatry and Addictions, Budapest, Hungary; Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.
¹² National Drug and Alcohol Research Center, University of New South Wales, Sydney, Australia.
¹³ Department of Psychiatry, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
¹⁴ University Hospital of Psychiatry and Psychotherapy, University of Bern, Switzerland.
¹⁵ Department for Substance Abuse Treatment, Østfold Hospital Trust, Norway.
¹⁶ Department of Psychiatry, Radboudumc, Donders Institute for Brain, Cognition and Behavior, Nijmegen Institute for Scientist Practitioners in Addiction (NISPA), Nijmegen, The Netherlands.
¹⁷ Bergen Clinics Foundation, Bergen, Norway.
¹⁸ ICASA Foundation, University of Amsterdam, Amsterdam, The Netherlands.
¹⁹ Arkin Mental Health and Addiction Treatment Center, Amsterdam, The Netherlands; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
²⁰ Psychiatric Center Mutiversum, Boechout, Belgium.
²¹ University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
²² Stockholm Centre for Dependency Disorders, Sweden.
²³ Columbia University, the New York State Psychiatric Institute, New York, NY, USA.
²⁴ Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
²⁵ Department of Psychiatry, Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Psychiatry and Forensic Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Electronic address: jaramos@vhebron.net.

PMID: 32561156
DOI: 10.1016/j.rpsm.2020.04.013

Abstract

Objective: This study aims to assess the validity of the ADHD module of the Mini-International Neuropsychiatric Interview (MINI-Plus) in patients with substance use disorders (SUD), using the Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID) as the external criterion.

Method: A cross sectional international multi-center study in 10 countries was conducted in treatment seeking SUD patients. A sample of 1263 patients with both MINI-Plus and CAADID was analyzed to determine the psychometric properties of the MINI-Plus.

Results: According to the CAADID, 179 patients (14.2%) met criteria for adult ADHD, whereas according to the MINI-Plus 227 patients (18.0%) were identified as having adult ADHD. Sensitivity of the MINI-Plus ADHD module was 74%, specificity was 91%, positive predictive value was 60% and negative predictive value was 96%. Kappa was 0.60.

Conclusion: The MINI-Plus has acceptable criterion validity for the screening of adult ADHD in treatment seeking SUD patients.

Scientific significance: On the basis of the results, The MINI-Plus may be used for the screening of ADHD in SUD patients.

Keywords: ADHD; Comorbidity; MINI; Psychometrics; Substance use disorder.

PubMed Disclaimer

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Affiliations

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Authors

Affiliations

Abstract

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous